# Epirubicin

## Epicin 10mg/5mL

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                 |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | IEP10                                                                                                                                                                                                                                                                                                                                                |
| 適應症     | Leukemia, lymphoma, breast cancer, sarcomas, small-cell lung carcinoma, ovarian cancer, gastric cancer. Liver cancer, head & neck cancer, pancreatic cancer.                                                                                                                                                                                         |
| 用法用量   | (仿單) Epirubicin should be administered intravenously or intravesicularly. Do not administer epirubicin orally, intramuscularly or subcutaneously. A lifetime maximum cumulative dose >1000 mg/m2 should be avoided. Usual dose: 75-90 mg/m2 intravenously once every 3 weeks. Intravesicular: 50 mg once weekly for 8 weeks; dose range: 30-80 mg. |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                           |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                         |
| 禁忌       | Myelosuppression. Cardiac impairment. Previous full cumulative doses of anthracyclines. Pregnancy. Lactation.                                                                                                                                                                                                                                        |
| 副作用     | Myelosuppression, cardiotoxicity, alopecia, mucositis, GI disturbances, hyperpyrexia.                                                                                                                                                                                                                                                                |
| 孕期建議   | Contraindicated – 1st trimester                                                                                                                                                                                                                                                                                                                      |
| 哺乳期建議 | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                       |

## EPICIN 50mg/25mL

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                 |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | IEP50                                                                                                                                                                                                                                                                                                                                                |
| 適應症     | Leukemia, lymphoma, breast cancer, sarcomas, small-cell lung carcinoma, ovarian cancer, gastric cancer. Liver cancer, head & neck cancer, pancreatic cancer.                                                                                                                                                                                         |
| 用法用量   | (仿單) Epirubicin should be administered intravenously or intravesicularly. Do not administer epirubicin orally, intramuscularly or subcutaneously. A lifetime maximum cumulative dose >1000 mg/m2 should be avoided. Usual dose: 75-90 mg/m2 intravenously once every 3 weeks. Intravesicular: 50 mg once weekly for 8 weeks; dose range: 30-80 mg. |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                           |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                         |
| 禁忌       | Myelosuppression. Cardiac impairment. Previous full cumulative doses of anthracyclines. Pregnancy. Lactation.                                                                                                                                                                                                                                        |
| 副作用     | Myelosuppression, cardiotoxicity, alopecia, mucositis, GI disturbances, hyperpyrexia.                                                                                                                                                                                                                                                                |
| 孕期建議   | Contraindicated – 1st trimester                                                                                                                                                                                                                                                                                                                      |
| 哺乳期建議 | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                       |

